Yüklüyor......
Phase II Study of Low-dose Paclitaxel and Cisplatin as a Second-line Therapy after 5-Fluorouracil/Platinum Chemotherapy in Gastric Cancer
This study was performed to evaluate the efficacy and toxicity of low-dose paclitaxel/cisplatin chemotherapy in patients with metastatic or recurrent gastric cancer that had failed 5-fluorouracil/platinum-based chemotherapy. Thirty-two patients with documented progression on or within 6 months after...
Kaydedildi:
Asıl Yazarlar: | , , , , , , , , , , , , , , , |
---|---|
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
The Korean Academy of Medical Sciences
2007
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2694374/ https://ncbi.nlm.nih.gov/pubmed/17923737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2007.22.S.S115 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|